Skip to content

Clinical trials

Phase 1/2 Metabolism, Inborn Errors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Phase: Phase 1/2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20214
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Terminated3
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.5
Alexion Pharmaceuticals, Inc.1
Children's Hospital of Philadelphia1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Forge Biologics, Inc1
LogicBio Therapeutics, Inc1
National Center for Research Resources (NCRR)1
NeuroGT1
SwanBio Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors13
Genetic Diseases, Inborn7
Metabolic Diseases6
Lysosomal Storage Diseases3
Mucopolysaccharidoses3
Acid-Base Imbalance2
Acidosis2
Amino Acid Metabolism, Inborn Errors2
Brain Diseases, Metabolic2
Brain Diseases, Metabolic, Inborn2

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.